Fundraising Fox
Nanocarry
Kadima-Tzoran, IL · Founded 2021 · 12 employees on LinkedIn · 2 known investors
Find your way into Nanocarry
Sign up to see every warm intro you have to Nanocarry
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nanocarry team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NanoCarry is developing a proprietary drug-delivery technology platform designed to move therapeutic antibodies across the blood-brain barrier for the treatment of brain cancers and central nervous system diseases. The platform uses a "Plug & Play" approach aimed at substantially increasing the brain delivery of injected antibody doses.
Founders & leadership
Nanocarry was founded in 2021 by Oshra Betzer.
Investors · 2
NFXlisted by NFXSan Francisco · $250K – $5M
How we know: funding news · Not right? Tell us
Sapir Venture Partnerslisted by Sapir Venture PartnersJerusalem
How we know: Sapir Venture Partners's portfolio page · funding news · Not right? Tell us
Frequently asked questions
- What does Nanocarry do?
- NanoCarry is developing a proprietary drug-delivery technology platform designed to move therapeutic antibodies across the blood-brain barrier for the treatment of brain cancers and central nervous system diseases. The platform uses a "Plug & Play" approach aimed at substantially increasing the brain delivery of injected antibody doses.
- Who founded Nanocarry?
- Nanocarry was founded by Oshra Betzer in 2021.
- Who are Nanocarry's investors?
- Nanocarry's investors include NFX, Sapir Venture Partners.
- Where is Nanocarry headquartered?
- Nanocarry is headquartered in Kadima-Tzoran, IL.